Morbius director responds to negative reviews: ‘I have a lot of self-hatred’

The new Marvel movie starring Jared Leto has been panned by critics

Inga Parkel
Wednesday 06 April 2022 10:30
Comments
Morbius - trailer

Morbius director Daniel Espinosa has responded to negative reviews of the film.

The new Marvel character adaptation stars Jared Leto as Dr Morbius, who is sick with a rare blood disorder and turns to a risky solution in order to save others from the same fate.

Since its 1 April release, the film has accumulated a host of negative criticism and a Rotten Tomatoes score of 16 per cent, making it one of the lowest-rated Marvel films to date.

In a recent interview with Insider, Espinosa was asked whether or not he paid attention to negative feedback.

“Look, I have a lot of self-hatred so I have a lot of criticism of my own work. I’m always trying to focus on being better. But I am also proud of what I do,” Espinosa said.

“It’s a strange thing to make something that is so public,” he added. “There are parts in all of my movies that I’m really proud of.”

The Independent’s Clarisse Loughrey was among many critics to give the film an unfavourable review, writing: “Morbius, from top to bottom, is a work of shameless corporate desperation.”

Jared Leto in ‘Morbius’

In addition to low ratings, its box office debut earned just $39.1m (£24m) during its US opening weekend and $84m (£64m) globally.

Comparatively, Marvel’s Avengers: Endgame (2019) made box office history with worldwide earnings of $2.7b (£2b).

Morbius is in cinemas now.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in